Evidence map›Paper›PMID 36765941›Full record

ReviewCancers2023

Global Longitudinal Strain in Cardio-Oncology: A Review.

Grzegorz Sławiński, Maja Hawryszko, Aleksandra Liżewska-Springer, Izabela Nabiałek-Trojanowska, Ewa Lewicka

Registry-linked trialAbstract readReview
In one paragraph

Review in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06695676 (Evaluation of Left Ventricle Systolic Functions of Patients On Lurasidone), which is not on this map. Cited by 52 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06695676 not yet recruitingnot on this mapstarted 2024, after this paper: background citation

Evaluation of Left Ventricle Systolic Functions of Patients On Lurasidone

Typeobservational_patient_registrySponsorAydin Adnan Menderes UniversityRan2024 to 2025Enrolled62ConditionsLurasidone Cardiotoxicity, Schizophrenia Patients, Bipolar DisordersArmsGlobal Longitudinal Strain
3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Structured exercise and cardiac outcomes during anthracycline or anti-HER2 therapy in breast cancer: systematic review and meta-analysis of randomized trials.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Caught in the crossfire: cardiac complications of cancer therapy.The Journal of clinical investigation · 2026
    Review
  19. Cardiotoxicity in breast cancer patients treated with chemoradiotherapy.Exploration of targeted anti-tumor therapy · 2026
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Grzegorz SławińskiDepartment of Cardiology and Heart Electrotherapy, Medical University of Gdańsk, 80-210 Gdańsk, Poland.ORCID 0000-0002-1974-6393
Maja HawryszkoDepartment of Cardiology and Heart Electrotherapy, Medical University of Gdańsk, 80-210 Gdańsk, Poland.
Aleksandra Liżewska-SpringerDepartment of Cardiology and Heart Electrotherapy, Medical University of Gdańsk, 80-210 Gdańsk, Poland.
Izabela Nabiałek-TrojanowskaCardio-Oncology Outpatient Clinic, University Clinical Center, 80-210 Gdańsk, Poland.
Ewa LewickaDepartment of Cardiology and Heart Electrotherapy, Medical University of Gdańsk, 80-210 Gdańsk, Poland.ORCID 0000-0002-0162-2659

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several therapies used in cancer treatment are potentially cardiotoxic and may cause left ventricular (LV) dysfunction and heart failure. For decades, echocardiography has been the main modality for cardiac assessment in cancer patients, and the parameter examined in the context of cardiotoxicity was the left ventricular ejection fraction (LVEF). The assessment of the global longitudinal strain (GLS) using speckle tracking echocardiography (STE) is an emerging method for detecting and quantifying subtle disturbances in the global long-axis LV systolic function. In the latest ESC guidelines on cardio-oncology, GLS is an important element in diagnosing the cardiotoxicity of oncological therapy. A relative decrease in GLS of >15% during cancer treatment is the recommended cut-off point for suspecting subclinical cardiac dysfunction. An early diagnosis of asymptomatic cardiotoxicity allows the initiation of a cardioprotective treatment and reduces the risk of interruptions or changes in the oncological treatment in the event of LVEF deterioration, which may affect survival.

Indexed as

cancer treatmentcardiotoxicityechocardiographyspeckle tracking echocardiographystrain

Identifiers

PMID36765941
PMCPMC9913863

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.